European Commission logo
français français
CORDIS - Résultats de la recherche de l’UE
CORDIS
Contenu archivé le 2024-05-23

Praziquantel: its central role in the chemotherapy of schistosome infection

Objectif

This proposal will be centred on aspects of praziquantel usage and will involve a group of scientists from disease endemic countries (with a major focus on Africa). They will be linked with a group of scientists from European Member States who share their common interest in researching the clinical, biological, epidemiological , pharmacological and socio-economic aspects of praziquantel use for the control of schistosome infection and disease. The Concerted Action will provide rational answers to questions related to the use of praziquantel in order to arm national health authorities and international agencies with appropriate information to ensure implementation of effective control programmes using praziquantel . The project will provide methodological tools to deal with any outbreak of drug resistant parasites and will develop strategies that if implemented will reduce the likelihood of emergence of drug resistant parasites

Programme(s)

Thème(s)

Data not available

Appel à propositions

Data not available

Régime de financement

CON - Coordination of research actions

Coordinateur

UNIVERSITY OF GLASGOW
Contribution de l’UE
Aucune donnée
Adresse
University Avenue, Joseph Black Building
G12 8QQ GLASGOW
Royaume-Uni

Voir sur la carte
Coût total
Aucune donnée

Participants (20)

Partager cette page

Télécharger

Dernière mise à jour: 12 Avril 2005

Mon livret

Permalink: https://cordis.europa.eu/project/id/ICA4-CT-2002-10054/fr

European Union, 2024